ES8506715A1 - 1'-bromo-2-fluorbencil)-7'-cloro-espiro (imidazolidina-4, 3'-indolina)-2, 2'-5-triona en forma racemica o dextrorrotativa - Google Patents

1'-bromo-2-fluorbencil)-7'-cloro-espiro (imidazolidina-4, 3'-indolina)-2, 2'-5-triona en forma racemica o dextrorrotativa

Info

Publication number
ES8506715A1
ES8506715A1 ES532215A ES532215A ES8506715A1 ES 8506715 A1 ES8506715 A1 ES 8506715A1 ES 532215 A ES532215 A ES 532215A ES 532215 A ES532215 A ES 532215A ES 8506715 A1 ES8506715 A1 ES 8506715A1
Authority
ES
Spain
Prior art keywords
racemic
bromo
indoline
triona
dextro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES532215A
Other languages
English (en)
Spanish (es)
Other versions
ES532215A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Publication of ES532215A0 publication Critical patent/ES532215A0/es
Publication of ES8506715A1 publication Critical patent/ES8506715A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES532215A 1983-05-05 1984-05-04 1'-bromo-2-fluorbencil)-7'-cloro-espiro (imidazolidina-4, 3'-indolina)-2, 2'-5-triona en forma racemica o dextrorrotativa Expired ES8506715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838312379A GB8312379D0 (en) 1983-05-05 1983-05-05 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
ES532215A0 ES532215A0 (es) 1985-08-01
ES8506715A1 true ES8506715A1 (es) 1985-08-01

Family

ID=10542245

Family Applications (1)

Application Number Title Priority Date Filing Date
ES532215A Expired ES8506715A1 (es) 1983-05-05 1984-05-04 1'-bromo-2-fluorbencil)-7'-cloro-espiro (imidazolidina-4, 3'-indolina)-2, 2'-5-triona en forma racemica o dextrorrotativa

Country Status (16)

Country Link
US (1) US4581366A (en, 2012)
EP (1) EP0125090B1 (en, 2012)
JP (1) JPS59206384A (en, 2012)
AU (1) AU2773184A (en, 2012)
DK (1) DK223484A (en, 2012)
ES (1) ES8506715A1 (en, 2012)
FI (1) FI841786A7 (en, 2012)
GB (1) GB8312379D0 (en, 2012)
GR (1) GR73868B (en, 2012)
HU (1) HU191685B (en, 2012)
IE (1) IE57356B1 (en, 2012)
IL (1) IL71735A (en, 2012)
NO (1) NO841778L (en, 2012)
NZ (1) NZ208059A (en, 2012)
PT (1) PT78527B (en, 2012)
ZA (1) ZA843375B (en, 2012)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU566869B2 (en) * 1982-05-11 1987-11-05 Imperial Chemical Industries Plc Spiro (imidazolidine-4,3'-indoline) 2,2',5-triones
GB8331194D0 (en) * 1982-12-20 1983-12-29 Ici Plc Chemical process
US5616722A (en) * 1995-12-05 1997-04-01 Mcintyre Group, Ltd. Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation
KR101228786B1 (ko) * 2005-08-25 2013-01-31 콜게이트-파아므올리브캄파니 보습 조성물
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives

Also Published As

Publication number Publication date
DK223484D0 (da) 1984-05-04
FI841786L (fi) 1984-11-06
ES532215A0 (es) 1985-08-01
EP0125090A2 (en) 1984-11-14
FI841786A0 (fi) 1984-05-04
IE841112L (en) 1984-11-05
PT78527A (en) 1984-06-01
US4581366A (en) 1986-04-08
IL71735A (en) 1987-07-31
GB8312379D0 (en) 1983-06-08
HU191685B (en) 1987-03-30
ZA843375B (en) 1985-01-30
PT78527B (en) 1986-09-15
IL71735A0 (en) 1984-09-30
NZ208059A (en) 1987-06-30
IE57356B1 (en) 1992-08-12
DK223484A (da) 1984-11-06
FI841786A7 (fi) 1984-11-06
HUT34195A (en) 1985-02-28
JPS59206384A (ja) 1984-11-22
EP0125090B1 (en) 1990-09-12
AU2773184A (en) 1984-11-08
EP0125090A3 (en) 1985-11-27
NO841778L (no) 1984-11-06
GR73868B (en, 2012) 1984-05-08

Similar Documents

Publication Publication Date Title
ES2115589T3 (es) Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
ES2054379T3 (es) Formas farmaceuticas orales de pimobendano.
AU4717189A (en) Low volatility amine salts of pesticides
AU8111798A (en) Resolution of amines
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
ES8506715A1 (es) 1'-bromo-2-fluorbencil)-7'-cloro-espiro (imidazolidina-4, 3'-indolina)-2, 2'-5-triona en forma racemica o dextrorrotativa
AT367036B (de) Verfahren zur herstellung von neuen, optisch aktiven 3-azabicyclo(3.1.0)hexanderivaten und ihren nichttoxischen, pharmazeutisch vertraeglichen salzen
BR9102466A (pt) Processo para a preparacao de um composto quimico e composto de piridina-dicarboxilato
SE9300758D0 (sv) Process for the production of clavulanic acid
ES2058154T3 (es) Un proceso para la preparacion de nuevos derivados disacaridos.
PT97541A (pt) Processo para a preparacao de indoles substituidos
IE38401L (en) Pyridinecarboxamide sulphamylurea derivatives
PT75597B (en) Process for the manufacture of sulfonamide-potenciator solutions
DE58902011D1 (de) Aufzeichnungstraeger.
ES8600759A1 (es) Procedimiento para preparar 2-(fenetil)-5-((3, 4-metilendioxi)- -hidroxibencil)-pirrolidina
ES8302093A1 (es) Un procedimiento para obtener nuevos compuestos de beta-lac-tama
ES2054870T3 (es) Procedimiento para producir (-) n-acetilaminocarnitina y (+) n-acetilaminocarnitina.
JPS5538397A (en) Diuretic drug
HK91086A (en) PROCESS FOR PREPARING 16α-HYDROXY-17α-AMINOPREGNANE DERIVATIVES
JPS56103142A (en) 22**nn*22hydroxyethyl**nnmethyl**amino** methylbenzophenone and manufacture of 22**nn*22hydroxyethyl**nnmethyl**amino** methylbenzhydrol employing it
EP0217376A3 (en) Process for preparing optically active alpha-haloalkyl-aprocess for preparing optically active alpha-haloalkyl-arylketones rylketones
NO175251C (no) Fremgangsmåte for racematspalting av 2,2-dimetylcyklopropankarboksylsyre
JPS6056224U (ja) 記録紙
SE8302747L (sv) Indol-naftyridiner
ES481927A1 (es) Procedimiento de preparar compuesto pirimidinicos en cabeza de puente de nitrogeno.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203